Premium
Panta rhei, also drug eluting stent technology
Author(s) -
Chiarito Mauro,
Mehran Roxana
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28918
Subject(s) - medicine , drug eluting stent , stent , observational study , revascularization , zotarolimus , randomized controlled trial , surgery , restenosis , myocardial infarction
Key Points The Resolute zotarolimus eluting stent (ZES) is a next‐generation durable polymer, thin‐struts drug eluting stent. Although several randomized and observational studies have proven its safety and efficacy, long‐term follow‐up data are still limited. This prospective, multicenter, single arm study, showed favorable 5‐year outcomes in patients undergoing Resolute ZES implantation, with considerably low rate of repeated revascularization and stent thrombosis. Data on long‐term performance of next‐generation drug eluting stents are of paramount importance to adequately inform decision‐making in contemporary clinical practice.